Search

Zyrtec-D - Risks of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome associated with the use of pseudoephedrine

$ 20.99 · 4.7 (285) · In stock

News From Nicholas Hall & Company, Nicholas Hall Company Blog

Drug-Induced Disorders of the Nervous System

Drug Office - Other safety alerts

Cerebrovascular Dysregulation: Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome.

Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions - ScienceDirect

Sci. Pharm., Free Full-Text

Frontiers Management and Clinical Outcome of Posterior Reversible Encephalopathy Syndrome in Pediatric Oncologic/Hematologic Diseases: A PRES Subgroup Analysis With a Large Sample Size

Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome as Syndromes of Cerebrovascular Dysregulation

Posterior reversible encephalopathy syndrome: A review with emphasis on neuroimaging characteristics - ScienceDirect